ClinicalTrials.Veeva

Menu

Vitamin D and Hypertensive Disorders of Pregnancy

TriHealth logo

TriHealth

Status

Not yet enrolling

Conditions

Hypertensive Disorders of Pregnancy

Treatments

Diagnostic Test: Vitamin D Levels measurement

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

The purpose of this study is to further investigate the association between vitamin D deficiency/insufficiency and hypertensive disorders of pregnancy by studying the impact of screening for vitamin D deficiency and supplementation when low levels of vitamin D are detected. Screening for vitamin D deficiency (less than 20 ng/mL) and insufficiency (less than 30 ng/mL) may determine the need for additional supplementation, as most prenatal vitamins only contain 400 IU of vitamin D. The rates of hypertensive disorders of pregnancy amongst patients who received supplementation and maintained adequate vitamin D levels will be followed.

Enrollment

594 estimated patients

Sex

Female

Ages

18 to 45 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Pregnant women
  • 18-45 years old
  • Receiving care at outpatient OB office of TriHealth's Women's Services Comprehensive OB-GYN Team with a plan to deliver at Bethesda North Hospital

Exclusion criteria

  • Non-English speaking
  • Unable to provide consent to research study participation
  • Diagnosis of preexisting renal disease
  • Diagnoses of preexisting chronic hypertension
  • Diagnosis of cardiovascular diseases
  • Diagnosis of conditions limiting fat absorption
  • Diagnosis of sarcoidosis

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Single Group Assignment

Masking

None (Open label)

594 participants in 2 patient groups

Arm 1: Standard OB care with no screening for vitamin D level.
No Intervention group
Description:
Patients will receive standard OB care with no screening for vitamin D level.
Arm 2: Vitamin D screening and supplementation if needed
Experimental group
Description:
Patients will receive standard OB care and will have a vitamin D level drawn with their other prenatal labs during an OB visit. If vitamin D insufficiency (less than 30 ng/mL) or deficiency (less than 20 ng/mL) is detected, the patient will be prescribed and provided a supplementation of 2000 IU of vitamin D daily for the remainder of the pregnancy.
Treatment:
Diagnostic Test: Vitamin D Levels measurement

Trial contacts and locations

0

Loading...

Central trial contact

Rachel B Baker

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems